HomeDCPXF • OTCMKTS
add
DanCann Pharma A/S
Market news
Financials
Income Statement
Revenue
Net income
| (DKK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.18M | -69.35% |
Operating expense | 1.77M | 2.61% |
Net income | -2.77M | -719.46% |
Net profit margin | -234.26 | -2,121.23% |
Earnings per share | — | — |
EBITDA | -2.24M | -1,080.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (DKK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | -38.00K | 94.62% |
Total assets | 13.38M | -34.85% |
Total liabilities | 4.60M | -67.55% |
Total equity | 8.77M | — |
Shares outstanding | 3.99M | — |
Price to book | 0.00 | — |
Return on assets | -48.84% | — |
Return on capital | -65.04% | — |
Cash Flow
Net change in cash
| (DKK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.77M | -719.46% |
Cash from operations | -849.00K | 74.35% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -68.00K | 98.07% |
Free cash flow | 637.25K | -52.41% |
About
Founded
2018
Website
Employees
5
